Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease

27 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium signaling and nucleotide metabolism
Share to Lysosomal Storage Disorders Research
Share to Neurogenetic and Muscular Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32719489
DOI: 10.1038/s41591-020-0986-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten diseasePMID 32719489Read ↗

Therapeutic antisense oligonucleotide mitigates retinal dysfunction in a pig model of CLN3 Batten diseaseSemantic proximity Read ↗

A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease.Semantic proximity Read ↗

Antisense Oligonucleotides for the Study and Treatment of ALSSemantic proximity Read ↗

Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative DiseasesSemantic proximity Read ↗

Clinical applications of exon-skipping antisense oligonucleotides in neuromuscular diseasesSemantic proximity Read ↗

Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1Semantic proximity Read ↗

Antisense oligonucleotide therapeutics for inherited neurodegenerative diseasesSemantic proximity Read ↗

The expanding application of antisense oligonucleotides to neurodegenerative diseasesSemantic proximity Read ↗

Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD DiseasesSemantic proximity Read ↗

Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 diseaseSemantic proximity Read ↗

Neurodegeneration and Epilepsy in a Zebrafish Model of CLN3 Disease (Batten Disease)Semantic proximity Read ↗

RNA-targeted Therapeutics for ALSSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.